ENCHANTED Main Results - Trial of low-dose versus standard-dose intravenous tissue plasminogen activator in 3310 patients with acute ischaemic stroke [invited speaker]
Type of Publication
Conference Paper
Year of Publication
2016
Conference Name
The 2nd European Stroke Organisation Conference
Language
Eng
Conference Location
Barcelona, Spain
Links to full text